These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 18752153

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL.
    Eur Urol; 2008 Apr; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.
    J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [Abstract] [Full Text] [Related]

  • 46. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.
    Urol Int; 2007 Oct; 78(4):328-33. PubMed ID: 17495491
    [Abstract] [Full Text] [Related]

  • 47. Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression.
    Aydin H, Tsuzuki T, Hernandez D, Walsh PC, Partin AW, Epstein JI.
    Urology; 2004 Sep; 64(3):551-5. PubMed ID: 15351591
    [Abstract] [Full Text] [Related]

  • 48. Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy.
    Hashimoto K, Masumori N, Takei F, Fukuta F, Takahashi A, Itoh N, Hasegawa T, Tsukamoto T.
    Jpn J Clin Oncol; 2008 Jan; 38(1):31-5. PubMed ID: 18203710
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Walz J, Chun FK, Klein EA, Reuther A, Graefen M, Huland H, Karakiewicz PI.
    Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.
    Schroeck FR, Sun L, Freedland SJ, Jayachandran J, Robertson CN, Moul JW.
    Prostate Cancer Prostatic Dis; 2008 Feb; 11(4):371-6. PubMed ID: 18427570
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location.
    Pettus JA, Weight CJ, Thompson CJ, Middleton RG, Stephenson RA.
    J Urol; 2004 Jul; 172(1):129-32. PubMed ID: 15201752
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Impact of surgical margin status on long-term cancer control after radical prostatectomy.
    Orvieto MA, Alsikafi NF, Shalhav AL, Laven BA, Steinberg GD, Zagaja GP, Brendler CB.
    BJU Int; 2006 Dec; 98(6):1199-203. PubMed ID: 17125478
    [Abstract] [Full Text] [Related]

  • 58. Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.
    Choo R, Danjoux C, Gardner S, Morton G, Szumacher E, Loblaw DA, Cheung P, Pearse M.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):407-12. PubMed ID: 19211197
    [Abstract] [Full Text] [Related]

  • 59. Prognostic factors of persistently detectable PSA after radical prostatectomy.
    Naselli A, Introini C, Andreatta R, Spina B, Truini M, Puppo P.
    Int J Urol; 2009 Jan 01; 16(1):82-6. PubMed ID: 19054168
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.